Voyageur Pharmaceuticals Ltd. VM.V
Health Care · Pharmaceuticals, Biotechnology & Life Sciences · TSX-V · Canada · voyageurpharmaceuticals.ca
Voyageur Pharmaceuticals Ltd. is a Calgary-based pharmaceutical company focused on the development and production of barium and iodine Active Pharmaceutical Ingredients (APIs) for medical imaging contrast agents. The company holds Health Canada licenses for five barium contrast products and has a collaboration with Bayer for iodine contrast media research and development, with plans to establish integrated manufacturing facilities in the United States.
Key ratios
FreeCashFlowOnSale TTM -73.64
FreeCashFlowOnSale 2025 -270.32
ReturnOnAssets TTM -0.58
ReturnOnAssets 2025 -0.63
ReturnOnAssets 2024 -0.4
ReturnOnAssets 2023 -0.36
ReturnOnEquity TTM -3.62
ReturnOnEquity 2025 -4.15
ReturnOnEquity 2024 -1.81
ReturnOnEquity 2023 -0.97
Recent news
Voyageur Pharmaceuticals Announces the Engagement of Red Cloud Securities as Market Maker
2026-07-17 · Newsfile
Voyageur Pharmaceuticals Engages Fluor to Advance Feasibility Studies for Iodine Production and Integrated Contrast Drug Manufacturing Facility
2026-06-23 · TheNewsWire
Voyageur Announces Shares for Debt Settlement and Stock Option Repricing
2026-04-17 · InvestorNews